ARCHIVE

• Tamiflu Leads Relenza on Market for Anti-flu Drugs
  April 15, 2002

• Copayment Hike to Reduce Patients' Visits to Hospitals: Survey
  April 15, 2002

• Entering US Market to Change Business Style of Japanese Firms: Analyst
  April 15, 2002

• Awareness of GL on COPD Low
  April 15, 2002

• Janssen: Sales Up 28.7% to \41.3 Billion
  April 15, 2002

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  April 15, 2002

• Otsuka, Otsuka Pharm Factory, Snow Brand Milk Create JV for Clinical Nutrition
  April 8, 2002

• Korosho to Construct Critical Path-Sharing System
  April 8, 2002

• Major Maker's New Invoice Prices Are More Acceptable than Before: Suzuken
  April 8, 2002

• Doctors' Participation in Clinical Trial Training Disappointing
  April 8, 2002

• BUSINESS NEWS IN BRIEF
  April 8, 2002

• RESEARCH AND DEVELOPMENT NEWS IN BRIEF
  April 8, 2002

• WEBSITE NEWS
  April 8, 2002

• Novartis Kao to Be Dissolved
  April 8, 2002

• EFPIA Japan to Strengthen European Makers' Presence
  April 8, 2002

• Pola Cosmetics Transfers Food Division to Asahi Beer Pharm
  April 8, 2002

• Committee Members Criticize Korosho's Healthcare Reform Bill
  April 8, 2002

• Pharmarise to Develop Private Brand Supplements
  April 8, 2002

• Monkasho to Create WG on Duality of Interest
  April 8, 2002

• WSMI Congress to Be Held in Tokyo in November
  April 8, 2002

ページ

• « 先頭
• ‹ Prev
• …
• 687
• 688
• 689
• 690
• 691
• 692
• 693
• 694
• 695
• …
• Next ›
• 最終 »